These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 39257308)

  • 1. Should renin-angiotensin system inhibitors be stopped or not before non-cardiac surgery?
    Halvorsen S; Vranckx P; van Diepen S
    Eur Heart J Acute Cardiovasc Care; 2024 Sep; 13(9):670-671. PubMed ID: 39257308
    [No Abstract]   [Full Text] [Related]  

  • 2. Navigating Renin-Angiotensin System Inhibitors in Patients with Declines in eGFR.
    Shulman R; Cohen JB
    J Am Soc Nephrol; 2024 Oct; 35(10):1309-1311. PubMed ID: 39137049
    [No Abstract]   [Full Text] [Related]  

  • 3. Blockers of the renin-angiotensin-aldosterone system: almost, but not yet, an absolute weapon against cardiovascular and renal diseases!
    Waeber B
    J Renin Angiotensin Aldosterone Syst; 2012 Mar; 13(1):216. PubMed ID: 22389390
    [No Abstract]   [Full Text] [Related]  

  • 4. Renin-Angiotensin System Modulation in Adults With COVID-19.
    Dos Santos RAS; Taccone FS; Annoni F
    JAMA; 2023 Aug; 330(7):663-664. PubMed ID: 37581678
    [No Abstract]   [Full Text] [Related]  

  • 5. Renin-Angiotensin System Modulation in Adults With COVID-19-Reply.
    Self WH; DeClercq J; Orr M;
    JAMA; 2023 Aug; 330(7):664-665. PubMed ID: 37581675
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of the renin-angiotensin-aldosterone system: how to obtain this.
    Pende A; Montecucco F
    Curr Pharm Des; 2012; 18(7):950-1. PubMed ID: 22283769
    [No Abstract]   [Full Text] [Related]  

  • 7. How should we modify recommended renin-angiotensin-aldosterone system inhibition when facing the cardiorenal syndrome?
    Sexton DJ
    Circ Heart Fail; 2014 May; 7(3):536. PubMed ID: 24847129
    [No Abstract]   [Full Text] [Related]  

  • 8. Pre- and/or Intra-Operative Prescription of Diuretics, but Not Renin-Angiotensin-System Inhibitors, Is Significantly Associated with Acute Kidney Injury after Non-Cardiac Surgery: A Retrospective Cohort Study.
    Tagawa M; Ogata A; Hamano T
    PLoS One; 2015; 10(7):e0132507. PubMed ID: 26146836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renin-angiotensin-aldosterone system inhibitors in heart failure.
    Shearer F; Lang CC; Struthers AD
    Clin Pharmacol Ther; 2013 Oct; 94(4):459-67. PubMed ID: 23852393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Renin-Angiotensin System Blockers on Mortality in Veterans Undergoing Cardiac Surgery.
    Antoniak DT; Walters RW; Alla VM
    J Am Heart Assoc; 2021 May; 10(10):e019731. PubMed ID: 33969701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Angiotensin-converting enzyme inhibitors and Angiotensin receptor antagonists in atherosclerosis prevention.
    Patarroyo Aponte MM; Francis GS
    Curr Cardiol Rep; 2012 Aug; 14(4):433-42. PubMed ID: 22562592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evolution of angiotensin blockade in the management of cardiovascular disease.
    Nantel P; René de Cotret P
    Can J Cardiol; 2010 Dec; 26 Suppl E():7E-13E. PubMed ID: 21620285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renin-angiotensin system inhibition is not associated with increased sudden cardiac death, cardiovascular mortality or all-cause mortality in patients with aortic stenosis.
    Bang CN; Greve AM; Køber L; Rossebø AB; Ray S; Boman K; Nienaber CA; Devereux RB; Wachtell K
    Int J Cardiol; 2014 Aug; 175(3):492-8. PubMed ID: 25012498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Juxtaglomerular apparatus hyperplasia under dual angiotensin blockade. A footprint of adequate RAS inhibition or a concern for renal fibrosis?
    Fernandez-Fernandez B; Ortiz A; Gomez-Guerrero C; Barat A; Martín-Cleary C; Egido J
    BMC Nephrol; 2012 Apr; 13():21. PubMed ID: 22533828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19.
    Vaduganathan M; Vardeny O; Michel T; McMurray JJV; Pfeffer MA; Solomon SD
    N Engl J Med; 2020 Apr; 382(17):1653-1659. PubMed ID: 32227760
    [No Abstract]   [Full Text] [Related]  

  • 16. The Role of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Postangioplasty Restenosis.
    Liu Y; Carrey Z; Aronow WS; Alaie D; Petrillo RL; Frishman WH
    Am J Ther; 2015; 22(4):e107-14. PubMed ID: 23782765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drugs and the renin-angiotensin system in covid-19.
    Aronson JK; Ferner RE
    BMJ; 2020 Apr; 369():m1313. PubMed ID: 32241880
    [No Abstract]   [Full Text] [Related]  

  • 18. Present and future in the treatment of diabetic kidney disease.
    Quiroga B; Arroyo D; de Arriba G
    J Diabetes Res; 2015; 2015():801348. PubMed ID: 25945357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved prognosis following renin-angiotensin-aldosterone system blockade in patients undergoing concomitant aortic and mitral valve replacement.
    Yiu KH; Ng WS; Chan D; Sit KY; Wong A; Lee CW; Chum HL; Cheng WY; Pun CT; Ho KL; Chen Y; Ho LM; Kumana CR; Cheung HL; Chung MC; Lau CP; Au WK; Tse HF
    Int J Cardiol; 2014 Dec; 177(2):680-2. PubMed ID: 25449483
    [No Abstract]   [Full Text] [Related]  

  • 20. Potential differential effects of renin-angiotensin system inhibitors on SARS-CoV-2 infection and lung injury in COVID-19.
    Furuhashi M; Moniwa N; Takizawa H; Ura N; Shimamoto K
    Hypertens Res; 2020 Aug; 43(8):837-840. PubMed ID: 32433641
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.